首页> 外文期刊>Colon & Rectum >Foxtrot Collaborative Group (2012) Lancet Oncol 13:1152-60 Feasibility of Preoperative Chemotherapy for Locally Advanced, Operable Colon Cancer: the Pilot Phase of a Randomised Controlled Trial
【24h】

Foxtrot Collaborative Group (2012) Lancet Oncol 13:1152-60 Feasibility of Preoperative Chemotherapy for Locally Advanced, Operable Colon Cancer: the Pilot Phase of a Randomised Controlled Trial

机译:Foxtrot协作小组(2012)柳叶赛甘蓝型13:1152-60术前化疗的可行性局部先进,可操作的结肠癌:随机对照试验的试验阶段

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Preoperative (neoadjuvant) chemotherapy and radiotherapy are more effective than similar postoperative treatment for oesophageal, gastric, and rectal cancers, perhaps because of more effective micrometastasis eradication and reduced risk of incomplete excision and tumour cell shedding during surgery. The Foxtrot trial aims to investigate the feasibility, safety, and efficacy of preoperative chemotherapy for colon cancer.
机译:背景:术前(Neoadjuvant)化疗和放射疗法比类似于食管,胃和直肠癌的术后治疗更有效,也许是因为在手术期间更有效的微转移和降低了不完全切除的切除和肿瘤细胞脱落的风险。 Foxtrot试验旨在探讨术前化学治疗结肠癌的可行性,安全性和功效。

著录项

  • 来源
    《Colon & Rectum》 |2018年第4期|共2页
  • 作者

    G. Meurette;

  • 作者单位

    Clinique de chimrgie digestive et endocrinienne CHU Hotel-Dieu 1 place Alexis-Ricordeau F-44000;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肠疾病;
  • 关键词

  • 入库时间 2022-08-19 23:58:50

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号